Stay updated on CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Sign up to get notified when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:15:13.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision label v3.3.1 was added and the previous v3.2.0 label was removed.
    Difference
    0.0%
    Check dated 2025-11-24T14:32:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's funding notice about government operations has been removed; the study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:50:10.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No significant changes to core study information (design, eligibility criteria, endpoints, or results) are evident between the screenshots; the differences appear limited to minor UI/formatting updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:18:14.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:34:19.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Update the page to a new revision: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:22:14.000Z thumbnail image

Stay in the know with updates to CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.